 | Registration No.: | PI/2007/X/645/MP |
|---|---|---|
| Name: | M Losery Stanly Paul | |
| M.S.(Pharm.) Thesis Title: | Flux Balance Analysis of Dihydrofolate reductase pathway of Leishmania species | |
| Connect at: | ||
| Research: 2 | ||
| Paul S, Nadendla S, Sobhia ME. Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches. The Journal of Physical Chemistry Letters 2022, 13: 7420-7428. | ||
| Paul ML, Kaur A, Geete A, Sobhia ME. Essential gene identification and drug target prioritization in Leishmania species. Molecular BioSystems 2014, 10: 1184-95. | ||
| Review: 1 | ||
| Sobhia ME, Grewal BK, Paul ML, Patel J, Kaur A, Haokip T and Kokkula A. Protein kinase C inhibitors: a patent review (2010 - present). Expert Opinion on Therapeutic Patents 2013, 23: 1451-68. | ||
| Books/Book Chapters: 0 | ||